September 2019 FDA Recall Drug by West-ward Columbus Inc
D-1863-2019 - Failed Impurities/Degradation Specificattion

This Class II drug recall was voluntarily initiated by West-ward Columbus Inc on September 9, 2019 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specificattion. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1863-2019

Reason for Recall
Failed Impurities/Degradation Specificattion
Initiated
09-09-2019
Reported
09-25-2019
Quantity
32,347 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
West-Ward Columbus Inc
Nationwide USA and Puerto Rico
Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59

Batch or Lot Expiration Information

Lot# Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020